|4Mar 3, 4:03 PM ET

Bassan Merav 4

4 · BiomX Inc. · Filed Mar 3, 2023

Insider Transaction Report

Form 4
Period: 2023-03-01
Bassan Merav
Chief Development Officer
Transactions
  • Award

    Common Stock Options - Right to Buy

    2023-03-01+100,000100,000 total
    Exercise: $0.40Exp: 2033-03-01Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 1, 2024, and the remainder vesting in 12 equal quarterly installments over three years.

Documents

1 file
  • 4
    ownership.xmlPrimary